Clearly more research on TMAO in different disease context as well as longitudinal studies are needed to understand the potential impact of this metabolite on biological systems in health and disease
Szczupak, B
Quick Answer: Tirzepatide is not FDA-approved to treat Hashimoto's disease itself but may be used on-label for weight management in patients with Hashimoto's who meet obesity treatment criteria (BMI 30 or BMI 27 with comorbidities)
Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ (2011) Assessment of flow-mediated dilation in humans: a methodological and physiological guideline
Additionally, oxidation of alcohol to acetaldehyde can occur in the stomach 35 , potentially explaining the increase in negative effects of alcohol reported in the social media study
are listed as co-inventors on provisional patent applications related to this work